Since 18 of December 2019 conferences.iaea.org uses Nucleus credentials. Visit our help pages for information on how to Register and Sign-in using Nucleus.

Multi-institutional clinical studies of chemoradiotherapy for cervical cancer among Asian countries under the framework of Forum for Nuclear Cooperation in Asia (FNCA)

21 Jun 2017, 10:03
8m

Speaker

Shingo Kato (Saitama Medical University, International Medical Centre)

Description

The Forum for Nuclear Cooperation in Asia is a Japan-led cooperation framework for peaceful and safe use of nuclear science and technology in Asia. Eleven Asian countries have been participating in the project. The purposes of the project are to establish safe and effective treatments for predominant cancers in Asia and to improve the treatment outcomes. Since 1995, four international clinical studies of radiotherapy and chemoradiotherapy for cervical cancer have been conducted in the project. At the first clinical study, there were many difficulties, including wide differences in the cultural and socio-economic status among countries, wide differences in cancer imaging, poor compliance with the protocol, and poor follow-up rate. With the dedicated efforts of the study group members, the recent clinical studies of chemoradiotherapy (the 3rd and 4th studies) were well-controlled, and favorable treatment outcomes were obtained from the studies.
Institution Saitama Medical University, International Medical Centre
Country Japan

Primary author

Shingo Kato (Saitama Medical University, International Medical Centre)

Co-authors

Masaru Wakatsuki (Jichi Medical University) Noriyuki Okonogi (National Institute of Radiological Sciences, Hospital, National Institutes for Quantum and Radiological Science and Technology, Japan) Takashi Nakano (Gunma University Graduate School of Medicine) Tatsuya Ohno (Heavy Ion Medical Centre, Gunma University)

Presentation materials

There are no materials yet.